论文部分内容阅读
目的:分析喜炎平注射液致药品不良反应(ADR)或药品不良事件(ADE)(简称ADR/ADE)患者发生的规律及特点,探讨其发生ADR/ADE的影响因素,为指导临床合理用药提供参考。方法:采用回顾性分析方法,分析江西青峰药业2016年度收集的253例喜炎平注射液致ADR/ADE病例信息。结果:253例患者中,其性别和年龄可能与喜炎平注射液致ADR/ADE发生的危险因素无关;ADR/ADE病例涉及原患疾病主要集中在呼吸系统疾病占67.69%;ADR/ADE病例累及器官/系统主要以皮肤及其附件损害(65.33%)为主,临床表现为皮疹、瘙痒、发热、寒战等常见的ADR/ADE症状;主要与抗菌药物联用发生ADR/ADE占66.30%。结论:喜炎平注射液致ADR/ADE的发生与患者身体状况和联合用药等因素相关,建议临床医生开方时重视询问患者的药物过敏史,以避免或减少ADR/ADE的发生,降低用药风险,合理使用喜炎平注射液。
OBJECTIVE: To analyze the regularity and characteristics of Xiyanping injection in patients with adverse drug reaction (ADR) or adverse drug reaction (ADE) (ADR / ADE) and to explore the influencing factors of ADR / ADE in order to guide clinical rational drug use for reference. Methods: A retrospective analysis method was used to analyze ADR / ADE case information of 253 cases of Xiyanping injection collected by Jiangxi Qingfeng Pharmaceutical in 2016. Results: The gender and age of 253 patients were not related to the risk factors of ADR / ADE induced by Xiyanping injection. The cases of ADR / ADE mainly involved the respiratory diseases accounted for 67.69% of ADR / ADE cases; ADR / ADE cases The main organ / systemic involvement was the damage of the skin and its accessory (65.33%). The clinical manifestations were common ADR / ADE symptoms such as rash, pruritus, fever and chills. The main ADR / ADE was 66.30% in combination with antimicrobial agents. Conclusion: The occurrence of ADR / ADE caused by Xiyanping injection is related to the physical condition of patients and the combination of drugs. It is suggested that clinicians should pay attention to the history of drug allergy when they prescribe prescription to avoid or reduce the occurrence of ADR / ADE and reduce the dosage Risk, rational use of Xiyanping injection.